UK govt’s CDC Group launches clean energy platform Ayana Renewable Power

By
Posted

Ayana Renewable Power will develop hundreds of megawatts of generation capacity for underserved Indian states and neighbouring countries in South Asia

BlackRock registers for private fund management in China

By

A private fund management registration will now allow it to sell onshore investment products to Chinese institutional and high net worth investors.


India: Vivimed Labs bags $7.5m additional investment from OrbiMed Asia

By

Vivid had earlier received $42.5 million from OrbiMed Asia in September 2017.


Jack Ma-backed Yunfeng takes part in $817m deal in Suning Finance

By

Yunfeng Capital is a private equity firm co-founded by Alibaba Group’s Jack Ma and 15 other investors.


Morgan Stanley, China’s Profex buy majority interest in Korres

By

Morgan Stanley, through its investment fund North Haven Private Equity Asia Maiden Holding B.V., has agreed to acquire 56% shares of Korres, while Profex, a pioneering dermatology and skincare company in China, will acquire 14%. NHPEA and Profex will subscribe for cash for a total of €48.3 million.


India: MedPlus promoter raises $115m debt to buy out PE investors

By

PE investors – US-based Mount Kellett Capital Management Lp, TVS Capital Funds Ltd and India Venture Advisors Pvt. Ltd – together held a 69% stake in MedPlus.


SoftBank – the Japanese backbone to India’s record funding year

By

During 2017, SoftBank made its biggest bets on Flipkart, Paytm, Ola and OYO.


India: PE sector sees record $24.4b inflow in 2017

By

Overall deal volume fell by 22% to 570 deals in 2017 from 726 in 2016, even as the average deal size surged to $42.8m from $21.2m. 


India sees food services sector return on private equity radar

By

India’s food services industry will be worth Rs4.98 trillion by 2021, according to a report by the National Restaurant Association of India.


SoftBank completes takeover of US private equity firm Fortress

By

The deal marks the first time a publicly traded U.S. private equity firm has delisted.